InvestorsHub Logo
Followers 0
Posts 44
Boards Moderated 0
Alias Born 07/13/2016

Re: bas2020 post# 111736

Wednesday, 07/19/2017 11:44:49 AM

Wednesday, July 19, 2017 11:44:49 AM

Post# of 461912
Amazing what a PR can do for any stock !!! AXON is now currently up 5% !

Axovant is evaluating intepirdine in MINDSET, a global, multi-center, double-blind, placebo-controlled Phase 3 study in subjects with mild to moderate Alzheimer's disease who are on stable background donepezil therapy, and expects to report topline results from this study in late September 2017.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News